Eisai’s Slow Push Toward Blockbuster Leqembi Sales Gains Steam with $900M Forecast
Eisai has reported a significant increase in sales for its Alzheimer’s disease treatment, Leqembi, forecasting…
Newswire
Arna Pharma and Slate Run Complete JV for New US Company
Arna Pharma and Slate Run Pharmaceuticals have finalized their joint venture to establish a new…
SCOTUS Temporarily Restores Telehealth Access to Abortion Pill Mifepristone
The U.S. Supreme Court has issued an emergency order, temporarily blocking a federal appeals court…
Kyowa Kirin secures FDA approval for Crysvita dosing update
Kyowa Kirin has received FDA approval for an updated dosing regimen for Crysvita, enhancing the…
As biologics dominate biopharma pipelines, manufacturing hurdles trip up new launches: report
As biologics have increasingly superseded small molecules in the biopharma industry’s pipeline, the mounting complexity…
Health execs persevere in new policy landscape
Despite a prolonged period of policy uncertainty in the U.S.—and the ripple effects across the…
PSA Screening for Prostate Cancer Reduces Disease-Specific Deaths, New Review Shows
Prostate-specific antigen (PSA) blood testing is likely to reduce the risk of death from prostate…
Supreme Court preserves access to widely used abortion pill, while lawsuit plays out
WASHINGTON — The Supreme Court on Thursday preserved women’s access to a drug used in…
FDA Enhances Access to Regulatory References for Drug Development
The FDA has launched a new initiative aimed at improving access to regulatory references pertinent…
CDER’s ARC Program Advances Rare Disease Regulatory Science Research
The Center for Drug Evaluation and Research (CDER) has launched the Accelerating Rare Disease Cures…